While HTT itself is cleaved by casp2 at aspartate-552 in vitro [6], this event is not crucial for development of HD because mutating this site does not confer protection from HD symptoms in a mouse model [18], and constitutive cleavage at this site is observed in control, as well as diseased, brains [7]. This evidence concerns the gene CASP2 and Huntington disease.